Patent details

LUC00214 Product Name: trastuzumab déruxtécan

Basic Information

Publication number:
LUC00214
Type:
SPC
SPC Type:
Medical
Basic Patent Number:
EP157437385
Legal Status:
Inactive
Application number:
LUC00214
First applicant's nationality:
Procedural language:
French

Marketing Authorization

Marketing Authorization Number:
EU/1/20/1508
Marketing Authorization Type:
Marketing Authorization Date:
20/01/2021
Marketing Authorization Status:
Accepted
Marketing Authorization Country:
Luxembourg (LU)

Dates

Filing date:
09/07/2021
First Marketing Authorization date:
20/01/2021
Grant date:
04/10/2024
Activation date:
Publication date:
09/07/2021
Lapsed date:
Expiration date:
Renunciation date:
Revocation date:
Annulment date:
Basic SPC Expiration:
20/01/2036
SPC Extension Expiration:
20/01/2036
Rejection date:
Withdrawal date:

Owner

From:
09/07/2021
 
 

Name:
Daiichi Sankyo Company, Limited
Address:
3-5-1, Nihonbashi Honcho Chuo-ku, Tokyo 103-8426, Japan (JP)

Agent

Name:
MARKS & CLERK LLP
From:
09/07/2021
Address:
BP 1775, 1017, LUXEMBOURG, Luxembourg (LU)
To:

Publication

Bulletin

1

Bulletin Heading:
SPC1
Bulletin edition number:
2021/09
Publication date:
03/08/2021
Description:
Section C : Published requests for Supplementary Protection Certificates – I1 publication

2

Bulletin Heading:
SPC2
Bulletin edition number:
2024/13
Publication date:
05/11/2024
Description:
Section D : Granted supplementary protection certificates – I2 publication

Annual Fees

Annual Fee Due Date:
31/01/2035
Annual Fee Number:
21
Annual Fee Amount:
410 Euro
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
09/07/2021 Incoming Correspondence (Post) 1
09/07/2021 General Document 3
09/07/2021 General Document 2
09/07/2021 Marketing authorization 3
09/07/2021 Summary of the product caracteristics 38
09/07/2021 Application Form 4
09/07/2021 MA publication 28
09/07/2021 General Document 6
09/07/2021 General Document 1
09/07/2021 Outgoing Correspondence 1
12/08/2022 Request For Change 1
02/09/2022 Outgoing Correspondence 56
09/07/2021 Publication 1
04/10/2024 Publication 1
04/10/2024 Certificate 1
04/10/2024 Outgoing Correspondence 1